Table 2

Clinical features of sporadic MEN1 cases and detected germline mutations

CaseAge at diagnosis*Sex*Parathyroid lesionsAnterior pituitary lesionsEnteropancreatic lesionsOther lesionsGermline MEN1 mutationLocationFamily examination, non-carriers
*Age at diagnosis and sex of probandus (F, female; M, male); NFT, non-functioning tumour; PRL, prolactinoma; ACTH, ACTH secreting tumour; GH, GH secreting tumour; Mixed tumour, prolactin and ACTH secreting tumour; I, insulinoma; G, gastrinoma; Gl, glucagonoma.
†Mutation not previously described. Fa, father; Mo, mother; S, son.
‡Results partially described by Cebrián et al.19
C6‡26FYesPRL848del4/ins9Exon 4
C10‡28MYesPRLIColagenomas355ins1Exon 2Fa, Mo
C2126MYesACTHR98XExon 2Fa, Mo
C2321MYesMixedIVS6+1G>AIntron 6Fa, Mo, S
C3335MYesPRLNFT357del4Exon 2Fa, Mo
C4134MYesGlSkin alterationsQ261XExon 4Fa, Mo
C4530MYesIW423R†Exon 9
C5435FYesNFTI, Gl357del4Exon 2
C415FYesPRL
C5‡52FYesGHThyroid adenoma
C960FYesGH
C1245MYesG
C1550FYesGH
C2557FYesG
C3454MNoNFTNFTMesenchymal tumour
C3566FYesG
C3981FYesG
C4238MYesGH
C5155FYesGH
C5341MYesNFTG316ins5Exon 2
C5744FYesGH
C6274FYesPRL
C6555FYesGH
C7239FYesGH
C7753FYesNFT
C7862MYesACTH
C8065FYesIAdrenal adenoma